Dataset: Expression data of the human hepatoblastoma cell line HepG2 treated with TGF-beta
Smad2/3 are transcription factors that engage in TGF-beta-induced transcription. We determined and analyzed HepG2 and Hep3B-specific...
Smad2/3 are transcription factors that engage in TGF-beta-induced transcription. We determined and analyzed HepG2 and Hep3B-specific Smad2/3 binding sites by ChIP-chip. We used expression microarrays to compare the Smad2/3 and HNF4alpha binding sites identified by ChIP-chip or ChIP-seq, respectively, to TGF-beta-induced gene expressions. HepG2 cells were transfected with control or HNF4A siRNAs and treated with 3 ng/ml TGF-beta for 0, 1.5 and 24 h (6 samples in total, no replicates). Total RNA was extracted and expression microarray analysis was performed as described in the protocols.
- Species:
- human
- Samples:
- 6
- Source:
- E-GEOD-28590
- PubMed:
- 21646355
- Updated:
- Dec.12, 2014
- Registered:
- Sep.16, 2014
Factors:
(via ArrayExpress)
Sample | SIRNA | TREATMENT | TREATMENT DURATION |
---|---|---|---|
GSM707672 | control | none | not specified |
GSM707673 | control | TGF-beta | 1.5 hrs |
GSM707674 | control | TGF-beta | 24 hrs |
GSM707675 | HNF4a | none | not specified |
GSM707676 | HNF4a | TGF-beta | 1.5 hrs |
GSM707677 | HNF4a | TGF-beta | 24 hrs |